We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has approved Acadia Pharmaceuticals’ Nuplazid to treat Parkinson’s disease in patients suffering from psychosis-related hallucinations and delusions. Read More
The EMA’s Committee for Medicinal Products for Human Use is recommending approval for six drugs within the EU and another for export-only from EU countries. Read More
Eagle Pharmaceuticals has made good on a threat to sue the FDA over its refusal to grant the company full exclusivity rights for its cancer drug Bendeka. Read More